作者
Masoud Dadashi, Bahareh Hajikhani, Davood Darban-Sarokhalil, Alex van Belkum, Mehdi Goudarzi
发表日期
2020/3/1
来源
Journal of global antimicrobial resistance
卷号
20
页码范围
238-247
出版商
Elsevier
简介
Objectives
Staphylococcus aureus is one of the most common pathogens causing nosocomial and community-acquired infections associated with high morbidity and mortality. Mupirocin has been increasingly used for treatment of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) infections. The aim of this study was to determine the prevalence of mupirocin-resistant S. aureus (MuRSA), mupirocin-resistant MRSA (MuRMRSA), high-level MuRSA (HLMuRSA) and high-level MuRMRSA (HLMuRMRSA) worldwide.
Methods
Online databases including Medline, Embase and Web of Science were searched (2000–2018) to identify studies addressing the prevalence of MuRSA, MuRMRSA, HLMuRSA and HLMuRMRSA. STATA v. software was used to interpret the data.
Results
Of the 2243 records identified from the databases, 30 and 63 studies fulfilled the eligibility criteria for MuRSA and …
引用总数
20202021202220232024722264418
学术搜索中的文章
M Dadashi, B Hajikhani, D Darban-Sarokhalil… - Journal of global antimicrobial resistance, 2020